An Open-label, Randomized, 3-arm, Parallel-group, Positive- and Negative-arm Controlled Study to Evaluate the Mineralocorticoid Receptor Antagonism Effect of Vamorolone in Healthy Subjects
Latest Information Update: 22 Oct 2024
At a glance
- Drugs Vamorolone (Primary) ; Eplerenone; Fludrocortisone
- Indications Duchenne muscular dystrophy
- Focus Pharmacokinetics
- Sponsors Santhera Pharmaceuticals
- 22 Oct 2024 New trial record